<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30093" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thrombocytopenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jinna</surname>
            <given-names>Sruthi</given-names>
          </name>
          <aff>Beaumont Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khandhar</surname>
            <given-names>Paras B.</given-names>
          </name>
          <aff>Beaumont Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sruthi Jinna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paras Khandhar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30093.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Thrombocytopenia is a platelet count below the lower limit of normal, i.e., 150000/microliter (for adults). This activity reviews the etiology, evaluation, and management of thrombocytopenia and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the etiology of thrombocytopenia.</p></list-item><list-item><p>Explain the appropriate history, physical, associated laboratory values, and evaluation of thrombocytopenia.</p></list-item><list-item><p>Summarize the treatment and management options available for thrombocytopenia.</p></list-item><list-item><p>Identify the importance of interprofessional team working together for improving care coordination and communication to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30093">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30093.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A platelet count that falls below the lower limit of normal, i.e., 150000/microliter (for adults) is defined as thrombocytopenia. Platelets are blood cells that help in blood clotting and wound healing &#x02014; risks associated with thrombocytopenia range from no risk at all to bleeding risks and thrombosis. The correlation of severity of thrombocytopenia and bleeding risk is uncertain. Spontaneous bleeding can occur with a platelet count under 10000/microliter and surgical bleeding with counts below 50000/microL. Thrombocytopenia is associated with risk of thrombosis in conditions like heparin-induced thrombocytopenia (HIT), antiphospholipid antibody syndrome (APS), disseminated intravascular coagulation (DIC), thrombotic microangiopathy (TMA), paroxysmal nocturnal hemoglobinuria (PNH).</p>
      </sec>
      <sec id="article-30093.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Common causes of thrombocytopenia<xref ref-type="bibr" rid="article-30093.r1">[1]</xref><xref ref-type="bibr" rid="article-30093.r2">[2]</xref><xref ref-type="bibr" rid="article-30093.r3">[3]</xref><xref ref-type="bibr" rid="article-30093.r4">[4]</xref><xref ref-type="bibr" rid="article-30093.r5">[5]</xref><xref ref-type="bibr" rid="article-30093.r6">[6]</xref><xref ref-type="bibr" rid="article-30093.r7">[7]</xref><xref ref-type="bibr" rid="article-30093.r8">[8]</xref><xref ref-type="bibr" rid="article-30093.r9">[9]</xref><xref ref-type="bibr" rid="article-30093.r10">[10]</xref>:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary immune thrombocytopenia (primary ITP). An autoimmune condition where antibodies are produced against platelets resulting in platelet destruction.</p>
          </list-item>
          <list-item>
            <p>Drug-induced immune thrombocytopenia:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Heparin-induced thrombocytopenia (HIT) - in this condition, anti-platelet antibodies activate platelets resulting in thrombosis (both arterial and venous)</p>
              </list-item>
              <list-item>
                <p>Quinine</p>
              </list-item>
              <list-item>
                <p>Sulfonamides, ampicillin, vancomycin, piperacillin</p>
              </list-item>
              <list-item>
                <p>Acetaminophen, ibuprofen, naproxen</p>
              </list-item>
              <list-item>
                <p>Cimetidine</p>
              </list-item>
              <list-item>
                <p>Glycoprotein IIb/IIIa inhibitors</p>
              </list-item>
              <list-item>
                <p>Other over the counter remedies, supplements, foods like African bean, sesame seeds, walnuts) and beverages (herbal teas and cranberry juice)</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Drug-induced non-immune thrombocytopenia. Drugs like valproic acid, daptomycin, linezolid cause thrombocytopenia by dose-dependent suppression of platelet production.</p>
          </list-item>
          <list-item>
            <p>Infections:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Viral: HIV, hepatitis C, Ebstein-Barr virus, parvovirus, mumps, varicella, rubella, Zika viral infections can cause thrombocytopenia.</p>
              </list-item>
              <list-item>
                <p>Sepsis causes bone marrow suppression.</p>
              </list-item>
              <list-item>
                <p>Helicobacter pylori</p>
              </list-item>
              <list-item>
                <p>Leptospirosis, brucellosis, anaplasmosis, and other tick-borne infections are associated with thrombocytopenia.</p>
              </list-item>
              <list-item>
                <p>Malaria, babesiosis intracellular parasite infections are associated with thrombocytopenia and hemolytic anemia</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Hypersplenism due to chronic liver disease</p>
          </list-item>
          <list-item>
            <p>Chronic alcohol abuse</p>
          </list-item>
          <list-item>
            <p>Nutrient deficiencies (folate, vitamin B12, copper)</p>
          </list-item>
          <list-item>
            <p>Autoimmune disorders like systemic lupus erythematosus, rheumatoid arthritis associated with secondary ITP</p>
          </list-item>
          <list-item>
            <p>Pregnancy. Mild thrombocytopenia presents in gestational thrombocytopenia; moderate-severe thrombocytopenia can occur in preeclampsia and HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome</p>
          </list-item>
        </list>
        <p>
<bold>Other causes<xref ref-type="bibr" rid="article-30093.r11">[11]</xref>:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Myelodysplasia</p>
          </list-item>
          <list-item>
            <p>Malignancy: cancer with chronic DIC, cancer with marrow suppression (leukemia, lymphoma, solid tumors)</p>
          </list-item>
          <list-item>
            <p>Paroxysmal nocturnal hemoglobinuria (PNH)</p>
          </list-item>
          <list-item>
            <p>Thrombotic microangiopathy (TMA)</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Thrombotic thrombocytopenic purpura (TTP), a condition manifested by fever, renal failure, thrombocytopenia, microangiopathic hemolytic anemia with or without neurologic manifestations</p>
              </list-item>
              <list-item>
                <p>A hemolytic uremic syndrome (HUS) caused by Shiga toxin-producing organism (E. coli and Shigella), seen in children.</p>
              </list-item>
              <list-item>
                <p>Drug-induced TMA: quinine, specific chemotherapy agents</p>
              </list-item>
              <list-item>
                <p>Antiphospholipid antibody syndrome</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Aplastic anemia</p>
          </list-item>
          <list-item>
            <p>Inherited thrombocytopenia. Often seen in children, rare in adults
<list list-type="bullet"><list-item><p>Von Willebrand disease type 2</p></list-item><list-item><p>Alport syndrome</p></list-item><list-item><p>Wiskott-Aldrich syndrome</p></list-item><list-item><p>Fanconi syndrome.</p></list-item><list-item><p>Thrombocytopenia-absent radius syndrome</p></list-item><list-item><p>Bernard&#x02013;Soulier syndrome</p></list-item><list-item><p>May-Hegglin anomaly</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30093.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Normal platelet count range varies by different ages, sexes, and ethnicity. Women, young individuals, and non-Hispanic blacks have slightly higher platelet counts.<xref ref-type="bibr" rid="article-30093.r12">[12]</xref></p>
      </sec>
      <sec id="article-30093.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Decreased platelet production<xref ref-type="bibr" rid="article-30093.r13">[13]</xref><xref ref-type="bibr" rid="article-30093.r14">[14]</xref><xref ref-type="bibr" rid="article-30093.r13">[13]</xref>:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bone marrow failure presents in aplastic anemia, PNH</p>
          </list-item>
          <list-item>
            <p>Bone marrow suppression is a feature with exposure to certain drugs, such as valproic acid, daptomycin, certain chemotherapy agents, and irradiation</p>
          </list-item>
          <list-item>
            <p>Chronic alcohol abuse</p>
          </list-item>
          <list-item>
            <p>Inherited thrombocytopenia)</p>
          </list-item>
          <list-item>
            <p>Viral infection</p>
          </list-item>
          <list-item>
            <p>Systemic conditions like nutrient deficiencies (folate, vitamin B12), sepsis, myelodysplastic syndrome impairs platelet production in the bone marrow - these conditions also associated with decreased production of other cell lines leading to anemia and leukopenia</p>
          </list-item>
        </list>
        <p>
<bold>Increased platelet destruction<xref ref-type="bibr" rid="article-30093.r15">[15]</xref><xref ref-type="bibr" rid="article-30093.r16">[16]</xref><xref ref-type="bibr" rid="article-30093.r17">[17]</xref><xref ref-type="bibr" rid="article-30093.r18">[18]</xref><xref ref-type="bibr" rid="article-30093.r14">[14]</xref><xref ref-type="bibr" rid="article-30093.r19">[19]</xref>:</bold>
</p>
        <p>In normal conditions, platelets get removed by monocytes/macrophages of the reticuloendothelial system. The life span of platelets is 8 to 10 days.</p>
        <p>In immune-mediated thrombocytopenia, anti-platelet autoantibodies bind to platelets and megakaryocytes, resulting in increased platelet destruction by the reticuloendothelial system and decreased platelet production.</p>
        <p>Anti-platelets antibodies are present in primary ITP, drug-induced ITP, lymphoproliferative disorders, autoimmune conditions like SLE and in chronic infections like HEP C, HIV, and Helicobacter pylori.</p>
        <p>Non-immune mediated increased platelet destruction occurs in mechanical valve replacement patients, preeclampsia/HELLP syndrome, DIC, and thrombotic microangiopathy. In conditions like DIC and thrombotic microangiopathy, increased platelet consumption within thrombi takes place.&#x000a0;</p>
        <p>
<bold>Dilutional thrombocytopenia<xref ref-type="bibr" rid="article-30093.r20">[20]</xref><xref ref-type="bibr" rid="article-30093.r21">[21]</xref>:</bold>
</p>
        <p>Dilutional thrombocytopenia presents in massive fluid resuscitation and massive blood transfusion.</p>
        <p>
<bold>Redistribution of platelets<xref ref-type="bibr" rid="article-30093.r22">[22]</xref>:</bold>
</p>
        <p>In normal individuals, one-third of platelet mass is in the spleen. In conditions that cause splenomegaly and increases spleen congestion (cirrhosis) results in increased platelet mass in spleen and a decrease in circulating platelets.</p>
      </sec>
      <sec id="article-30093.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><bold>Review of peripheral blood smear.&#x000a0;</bold>Analysis of platelet size and morphology helps in identifying conditions that are associated with platelet destruction and increased platelet consumption.</p>
        <list list-type="bullet">
          <list-item>
            <p>Clumping of platelets occurs when EDTA is used as anticoagulant causing pseudothrombocytopenia.<xref ref-type="bibr" rid="article-30093.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Adhesion of platelets to polymorphonuclear cells is known as &#x0201c;platelet satellitism&#x0201d; can be identified by review of a peripheral blood smear.<xref ref-type="bibr" rid="article-30093.r24">[24]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Giant platelets present in inherited conditions like Bernard-Soulier syndrome.</p>
          </list-item>
        </list>
        <p>A review of WBC and RBC morphology may suggest a specific condition.</p>
        <list list-type="bullet">
          <list-item>
            <p>Schistocytes are a feature in thrombotic microangiopathic conditions.</p>
          </list-item>
          <list-item>
            <p>Teardrop cells, nucleated RBCs, leukoerythroblastic findings suggest bone marrow infiltrative process.</p>
          </list-item>
          <list-item>
            <p>Immature WBCs suggest leukemia.</p>
          </list-item>
          <list-item>
            <p>Megaloblastic process characterized by hypersegmented neutrophils seen in nutritional deficiencies.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30093.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p><bold>History.&#x000a0;</bold>Obtaining a thorough history helps to identify the etiology of thrombocytopenia.&#x000a0;Patients with platelets greater than 50000/mL, rarely have symptoms. Patients with platelets under 20000/mL most likely have spontaneous bleeding.</p>
        <list list-type="bullet">
          <list-item>
            <p>Ask the patient about the prior blood count testing and baseline platelet count. The recent drop in platelet count is concerning.</p>
          </list-item>
          <list-item>
            <p>Ask for the history of bleeding (petechiae, hemorrhagic bleeding, gingival bleeding, epistaxis)</p>
          </list-item>
          <list-item>
            <p>Ask for any potential exposure and symptoms of infections (viral, bacterial, rickettsial). Assess risk factors for HIV infection. Ask about travel to an area endemic for malaria <xref ref-type="bibr" rid="article-30093.r25">[25]</xref>&#x000a0;<xref ref-type="bibr" rid="article-30093.r26">[26]</xref>, dengue virus, and Ebola.</p>
          </list-item>
          <list-item>
            <p>Obtain a diet history to detect any nutritional deficiencies.</p>
          </list-item>
          <list-item>
            <p>Ask about other conditions like SLE, RA, bariatric surgery, and blood transfusion.</p>
          </list-item>
          <list-item>
            <p>Review the medication list. Ask whether the patient is taking over the counter medications, quinine-containing beverages, and herbal teas.</p>
          </list-item>
          <list-item>
            <p>In the hospitalized patient, look for exposure to heparin products.</p>
          </list-item>
          <list-item>
            <p>Check for a family history of thrombocytopenia or bleeding disorders.</p>
          </list-item>
          <list-item>
            <p>In pregnant patients ask for headache, visual symptoms, abdominal pain, flu-like symptoms; these patients may have preeclampsia/HELLP syndrome.</p>
          </list-item>
        </list>
        <p><bold>Physical Examination</bold> includes examining the skin and other sites of bleeding and examination of liver, spleen, and lymph nodes. Bleeding caused by thrombocytopenia characteristically demonstrates petechiae, nonpalpable purpura, and ecchymosis. Dry purpura refers to purpura in the skin; wet purpura refers to purpura in the mucosa. Examine for hepatomegaly and splenomegaly which occur in lymphoma, chronic liver disease, and other hematologic conditions. Enlarged lymph nodes are present in infections, autoimmune disorders, lymphoma, and other malignancies.</p>
      </sec>
      <sec id="article-30093.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of patients with isolated thrombocytopenia includes obtaining a CBC, peripheral blood smear, HIV, and HCV tests.</p>
        <list list-type="bullet">
          <list-item>
            <p>Repeat CBC to confirm that thrombocytopenia is real.</p>
          </list-item>
          <list-item>
            <p>Anemia and thrombocytopenia occur with infections, DIC, sepsis, thrombotic microangiopathy, autoimmune disorders like Felty syndrome. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Leucocytosis and thrombocytopenia can present in infection, malignancy, chronic inflammatory conditions.</p>
          </list-item>
          <list-item>
            <p>Pancytopenia occurs in myelodysplastic syndromes.</p>
          </list-item>
          <list-item>
            <p>In patients with symptoms or signs of autoimmune disorders like SLE, antiphospholipid antibody syndrome (APS), obtain anti-nuclear antibodies and antiphospholipid antibodies, respectively.</p>
          </list-item>
          <list-item>
            <p>In patients with thrombosis, one should consider heparin-induced thrombocytopenia (obtain platelet factor 4 antibodies), APS (check antiphospholipid antibodies ), DIC and PNH (check PT,aPTT, fibrinogen, LDH)</p>
          </list-item>
          <list-item>
            <p>Check liver enzymes and coagulation tests in patients with liver disease.</p>
          </list-item>
          <list-item>
            <p>Bone marrow biopsy is indicated in conditions when the cause of thrombocytopenia is unclear, and when a hematologic disorder is suspected.
<list list-type="bullet"><list-item><p>A normal number or rise in megakaryocytes in bone marrow is a presenting feature in conditions with increased platelet destruction.</p></list-item><list-item><p>The decrease in megakaryocytes, along with an overall reduction in other cells, is seen in aplastic anemia.</p></list-item><list-item><p>In SLE, severe reduction or absence of megakaryocytes is seen due to an autoantibody directed against the thrombopoietin receptor.</p></list-item><list-item><p>Megaloblastic changes in RBC and granulocytes occur in vitamin B12, folate, and copper deficiency. In myelodysplasia, cells are dysplastic.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30093.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In asymptomatic, mild thrombocytopenia patients, repeat CBC and routine monitoring is the recommended process.</p>
        <p>Thrombocytopenic emergencies that require immediate action includes conditions of suspected HIT, TTP, HUS, drug-induced ITP, pregnancy with severe thrombocytopenia, bleeding with severe thrombocytopenia, urgently needed an invasive procedure in the presence of severe thrombocytopenia, leukopenia, and aplastic anemia.</p>
        <p>In patients with bleeding and severe thrombocytopenia, treatment includes platelet transfusion. &#x000a0;</p>
        <p>Management includes identifying the underlying cause and treating it.</p>
        <p>
<bold>Primary immune thrombocytopenia:</bold>
</p>
        <p>This condition is a diagnosis of exclusion. First line treatment includes glucocorticoids and intravenous immune globulins; these agents inhibit autoantibody production and platelet degradation. Second line treatment includes rituximab, immunosuppressive drugs, and splenectomy. Third line agents are thrombopoietin receptor agonists, which stimulate platelet production.<xref ref-type="bibr" rid="article-30093.r27">[27]</xref></p>
        <p>
<bold>Drug-induced thrombocytopenia:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Withholding the causative drug usually results in improvement of platelet counts in cases of drug-induced thrombocytopenia.</p>
          </list-item>
          <list-item>
            <p>The mainstay of treatment in HIT is to withdraw all heparin products and to initiate anti-thrombin and anti-Xa activity anticoagulant agents. Dicoumarol agents added once platelet count reaches normal.<xref ref-type="bibr" rid="article-30093.r28">[28]</xref><xref ref-type="bibr" rid="article-30093.r29">[29]</xref><xref ref-type="bibr" rid="article-30093.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>TTP gets treated with plasma exchange.<xref ref-type="bibr" rid="article-30093.r31">[31]</xref></p>
        <p>In patients with secondary ITP managing the underlying condition is recommended, like, in SLE, SLE treatment is with immunosuppressive agents, and in patients with H. pylori-associated thrombocytopenia, eradication of H.pylori increases platelet count.<xref ref-type="bibr" rid="article-30093.r32">[32]</xref><xref ref-type="bibr" rid="article-30093.r33">[33]</xref></p>
      </sec>
      <sec id="article-30093.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Psuedothrombocytopenia: Invitro platelet clumping results from ethylenediaminetetracetic acid (EDTA) dependent agglutinins, inadequately anticoagulated specimen, glycoprotein IIb/IIIa inhibitors. Giant platelets are counted as white blood cells rather than platelets by an automated counter.</p>
      </sec>
      <sec id="article-30093.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>A prospective study, it was found that patients with mild thrombocytopenia (100000 to 150000/microliter) have a 10-year probability of developing autoimmune disorders of 12 %.<xref ref-type="bibr" rid="article-30093.r34">[34]</xref></p>
      </sec>
      <sec id="article-30093.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Severe thrombocytopenia is associated with severe internal bleeding. Bleeding in the brain is fatal.</p>
        <p>In heparin-induced thrombosis (HIT), arterial and venous thrombosis is seen leading to deep venous thrombosis, pulmonary embolism, cerebrovascular accident, and myocardial infarction.<xref ref-type="bibr" rid="article-30093.r35">[35]</xref></p>
        <p>Antiphospholipid antibody syndrome associated with arterial and venous thrombosis, and abortions.<xref ref-type="bibr" rid="article-30093.r36">[36]</xref><xref ref-type="bibr" rid="article-30093.r37">[37]</xref></p>
        <p>In TTP microvascular thrombosis involving various organ systems predominantly central nervous system, whereas in HUS kidneys are affected.</p>
      </sec>
      <sec id="article-30093.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Newly- diagnosed patients with thrombocytopenia are referred to a hematologist to confirm the diagnosis. In patients with unexplained thrombocytopenia, consulting hematologist is the recommendation. Immediate consultation is necessary for conditions like TTP, HUS, HIT, aplastic anemia, leukemia, and other bone marrow failure conditions.</p>
        <p>Pregnant patients with HELLP/preeclampsia require an obstetrician consultation.</p>
      </sec>
      <sec id="article-30093.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Educate patients about activity restrictions. Patients with a platelet count over 50000/mL should be cautious while participating in contact sports. Restriction from contact sports and other potentially traumatic activities is recommended in patients with platelets count under 10000/ mL.<xref ref-type="bibr" rid="article-30093.r34">[34]</xref><xref ref-type="bibr" rid="article-30093.r38">[38]</xref></p>
        <p>Educate patients that certain over the counter medications like aspirin, Non-steroidal anti-inflammatory drugs, and ginkgo biloba interfere with platelet function. Educate patients about quinine-containing beverages and herbal teas, causing the low platelet count.</p>
      </sec>
      <sec id="article-30093.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Due to the complexity of this condition, management of emergent thrombocytopenic conditions requires an interprofessional team of health care professionals, including specialty-trained nursing, pharmacists, physicians, and specialists working together collaboratively to achieve optimal patient outcomes.</p>
      </sec>
      <sec id="article-30093.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30093">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/thrombocytopenia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30093">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30093/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30093">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30093.s17">
        <title>References</title>
        <ref id="article-30093.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced immune thrombocytopenia.</article-title>
            <source>J Pharm Pract</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>430</fpage>
            <page-range>430-9</page-range>
            <pub-id pub-id-type="pmid">25134884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LAVY</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>THROMBOCYTOPENIC PURPURA DUE TO LUPINUS TERMIS BEAN.</article-title>
            <source>J Allergy</source>
            <year>1964</year>
            <season>Sep-Oct</season>
            <volume>35</volume>
            <fpage>386</fpage>
            <page-range>386-9</page-range>
            <pub-id pub-id-type="pmid">14216353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnold</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ouwehand</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A young woman with petechiae.</article-title>
            <source>Lancet</source>
            <year>1998</year>
            <month>Aug</month>
            <day>22</day>
            <volume>352</volume>
            <issue>9128</issue>
            <fpage>618</fpage>
            <pub-id pub-id-type="pmid">9746024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achterbergh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vermeer</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Porcelijn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aster</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Deenik</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Daemen-Gubbels</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia in a nutshell.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Feb</month>
            <day>25</day>
            <volume>379</volume>
            <issue>9817</issue>
            <fpage>776</fpage>
            <pub-id pub-id-type="pmid">22364760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azuno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yaga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sasayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kimoto</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia induced by Jui, a traditional Chinese herbal medicine.</article-title>
            <source>Lancet</source>
            <year>1999</year>
            <month>Jul</month>
            <day>24</day>
            <volume>354</volume>
            <issue>9175</issue>
            <fpage>304</fpage>
            <page-range>304-5</page-range>
            <pub-id pub-id-type="pmid">10440313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohmori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hagihara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sekido</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Acute thrombocytopenia induced by jui, a traditional herbal medicine.</article-title>
            <source>J Thromb Haemost</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>1479</fpage>
            <page-range>1479-80</page-range>
            <pub-id pub-id-type="pmid">15304064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Ahktar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ranasinge</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A juicy problem.</article-title>
            <source>Lancet</source>
            <year>2001</year>
            <month>Dec</month>
            <day>22-29</day>
            <volume>358</volume>
            <issue>9299</issue>
            <fpage>2126</fpage>
            <pub-id pub-id-type="pmid">11784628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Raskob</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Rizvi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Osborne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vondracek</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced thrombocytopenia: a systematic review of published case reports.</article-title>
            <source>Ann Intern Med</source>
            <year>1998</year>
            <month>Dec</month>
            <day>01</day>
            <volume>129</volume>
            <issue>11</issue>
            <fpage>886</fpage>
            <page-range>886-90</page-range>
            <pub-id pub-id-type="pmid">9867731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scaradavou</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>HIV-related thrombocytopenia.</article-title>
            <source>Blood Rev</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-6</page-range>
            <pub-id pub-id-type="pmid">11914001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karimi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Goorhuis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schinkel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Codrington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vreden</surname>
                <given-names>SGS</given-names>
              </name>
              <name>
                <surname>Vermaat</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Stijnis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grobusch</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Mar</month>
            <day>05</day>
            <volume>387</volume>
            <issue>10022</issue>
            <fpage>939</fpage>
            <page-range>939-940</page-range>
            <pub-id pub-id-type="pmid">26906627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clare</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Montiel</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Lifschitz</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Bannayan</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Alport's syndrome associated with macrothrombopathic thrombocytopenia.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1979</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-7</page-range>
            <pub-id pub-id-type="pmid">453097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Segal</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Moliterno</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Platelet counts differ by sex, ethnicity, and age in the United States.</article-title>
            <source>Ann Epidemiol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-30</page-range>
            <pub-id pub-id-type="pmid">16246584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veneri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Franchini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Randon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nichele</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pizzolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ambrosetti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenias: a clinical point of view.</article-title>
            <source>Blood Transfus</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-85</page-range>
            <pub-id pub-id-type="pmid">19503627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franchini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veneri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia and infections.</article-title>
            <source>Expert Rev Hematol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-106</page-range>
            <pub-id pub-id-type="pmid">27936979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mason</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Carpinelli</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Collinge</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hilton</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Ekert</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Metcalf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Kile</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Programmed anuclear cell death delimits platelet life span.</article-title>
            <source>Cell</source>
            <year>2007</year>
            <month>Mar</month>
            <day>23</day>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>1173</fpage>
            <page-range>1173-86</page-range>
            <pub-id pub-id-type="pmid">17382885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowling</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Josefsson</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Henley</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hodgkin</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Kile</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Platelet senescence is regulated by an internal timer, not damage inflicted by hits.</article-title>
            <source>Blood</source>
            <year>2010</year>
            <month>Sep</month>
            <day>09</day>
            <volume>116</volume>
            <issue>10</issue>
            <fpage>1776</fpage>
            <page-range>1776-8</page-range>
            <pub-id pub-id-type="pmid">20530288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stasi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Immune thrombocytopenia: pathophysiologic and clinical update.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>454</fpage>
            <page-range>454-62</page-range>
            <pub-id pub-id-type="pmid">22753097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Budman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Steinberg</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Hematologic aspects of systemic lupus erythematosus. Current concepts.</article-title>
            <source>Ann Intern Med</source>
            <year>1977</year>
            <month>Feb</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>220</fpage>
            <page-range>220-9</page-range>
            <pub-id pub-id-type="pmid">835948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuwana</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.</article-title>
            <source>World J Gastroenterol</source>
            <year>2014</year>
            <month>Jan</month>
            <day>21</day>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>714</fpage>
            <page-range>714-23</page-range>
            <pub-id pub-id-type="pmid">24574745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leslie</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Toy</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>96</volume>
            <issue>6</issue>
            <fpage>770</fpage>
            <page-range>770-3</page-range>
            <pub-id pub-id-type="pmid">1746495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Counts</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Haisch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Maxwell</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Heimbach</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Carrico</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Hemostasis in massively transfused trauma patients.</article-title>
            <source>Ann Surg</source>
            <year>1979</year>
            <month>Jul</month>
            <volume>190</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-9</page-range>
            <pub-id pub-id-type="pmid">464685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aster</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.</article-title>
            <source>J Clin Invest</source>
            <year>1966</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>645</fpage>
            <page-range>645-57</page-range>
            <pub-id pub-id-type="pmid">5327481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mant</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Doery</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gauldie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sims</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA.</article-title>
            <source>Scand J Haematol</source>
            <year>1975</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>161</fpage>
            <page-range>161-70</page-range>
            <pub-id pub-id-type="pmid">812172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heyderman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Platelet satellitism.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Jul</month>
            <day>09</day>
            <volume>339</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-2</page-range>
            <pub-id pub-id-type="pmid">9669908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladhani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khatri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>El-Bashir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shingadia</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imported malaria is a major cause of thrombocytopenia in children presenting to the emergency department in east London.</article-title>
            <source>Br J Haematol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>5</issue>
            <fpage>707</fpage>
            <page-range>707-9</page-range>
            <pub-id pub-id-type="pmid">15916695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Niranjan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia in malaria.</article-title>
            <source>J Natl Med Assoc</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>96</volume>
            <issue>9</issue>
            <fpage>1212</fpage>
            <page-range>1212-4</page-range>
            <pub-id pub-id-type="pmid">15481750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blickstein</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].</article-title>
            <source>Harefuah</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>158</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-199</page-range>
            <pub-id pub-id-type="pmid">30916510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakchoul</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Drug-associated thrombocytopenia.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2018</year>
            <month>Nov</month>
            <day>30</day>
            <volume>2018</volume>
            <issue>1</issue>
            <fpage>576</fpage>
            <page-range>576-583</page-range>
            <pub-id pub-id-type="pmid">30504360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Wallis</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Berkowitz</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Matthai</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Fareed</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walenga</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bartholomew</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sham</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lerner</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Zeigler</surname>
                <given-names>ZR</given-names>
              </name>
              <name>
                <surname>Rustagi</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Rifkin</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hursting</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kelton</surname>
                <given-names>JG</given-names>
              </name>
              <collab>ARG-911 Study Investigators</collab>
            </person-group>
            <article-title>Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Apr</month>
            <day>10</day>
            <volume>103</volume>
            <issue>14</issue>
            <fpage>1838</fpage>
            <page-range>1838-43</page-range>
            <pub-id pub-id-type="pmid">11294800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alving</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>How I treat heparin-induced thrombocytopenia and thrombosis.</article-title>
            <source>Blood</source>
            <year>2003</year>
            <month>Jan</month>
            <day>01</day>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-7</page-range>
            <pub-id pub-id-type="pmid">12393689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rock</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Shumak</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Buskard</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Blanchette</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Kelton</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Spasoff</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>Aug</month>
            <day>08</day>
            <volume>325</volume>
            <issue>6</issue>
            <fpage>393</fpage>
            <page-range>393-7</page-range>
            <pub-id pub-id-type="pmid">2062330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veneri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Franchini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gottardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Adda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ambrosetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krampera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zanetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pizzolo</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura.</article-title>
            <source>Haematologica</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>87</volume>
            <issue>11</issue>
            <fpage>1177</fpage>
            <page-range>1177-9</page-range>
            <pub-id pub-id-type="pmid">12414347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McCune</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of primary and secondary immune thrombocytopenia.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2019</year>
            <month>May</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-222</page-range>
            <pub-id pub-id-type="pmid">30920453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stasi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Amadori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Newland</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Provan</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia.</article-title>
            <source>PLoS Med</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>e24</fpage>
            <pub-id pub-id-type="pmid">16401142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franchini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Heparin-induced thrombocytopenia: an update.</article-title>
            <source>Thromb J</source>
            <year>2005</year>
            <month>Oct</month>
            <day>04</day>
            <volume>3</volume>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">16202170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finazzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brancaccio</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciaverella</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mazzucconi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Schinco</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Ruggeri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pogliani</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Gamba</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baudo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Manotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D'Angelo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palareti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Stefano</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Berrettini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbui</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.</article-title>
            <source>Am J Med</source>
            <year>1996</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>530</fpage>
            <page-range>530-6</page-range>
            <pub-id pub-id-type="pmid">8644765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lockshin</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Druzin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Goei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qamar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Magid</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Jovanovic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ferenc</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.</article-title>
            <source>N Engl J Med</source>
            <year>1985</year>
            <month>Jul</month>
            <day>18</day>
            <volume>313</volume>
            <issue>3</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">3925336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30093.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacey</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Penner</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Management of idiopathic thrombocytopenic purpura in the adult.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>1977</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-74</page-range>
            <pub-id pub-id-type="pmid">322290</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
